The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding ...
A disruption of current HIV/Aids mitigation programmes in southern Africa will lead to decreased access to critical treatments and preventive therapies, which will in turn lead to increased mortality ...